Companies: 10,795·Total market cap: $144.5T
Molecular Partners AG

Molecular Partners AG

MOLNNASDAQHealthcare● Active
$3.95
$-0.15(-3.66%)
Market Cap$148168932
P/E Ratio
52W High$5.36
52W Low$3.41

Molecular Partners AG(MOLN)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · MOLN · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.00B$0.00B$0.01B$0.19B$0.01B
Cost of Revenue$0.00B$0.05B$0.05B$0.05B$0.06B
Gross Profit$0.00B($0.04B)($0.04B)$0.14B($0.05B)
Gross Margin %(computed)-855.81%-579.80%73.23%-497.19%
Operating Expenses
R&D Expenses$0.04B$0.05B$0.05B$0.05B$0.06B
G&A Expenses$0.01B$0.02B$0.02B$0.02B$0.02B
Total Operating Expenses$0.06B$0.02B$0.02B$0.07B$0.07B
Operating Income($0.06B)($0.06B)($0.06B)$0.12B($0.06B)
Operating Margin %(computed)-868.26%61.52%-679.72%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.06B)($0.05B)($0.06B)$0.12B($0.06B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.06B)($0.05B)($0.06B)$0.12B($0.06B)
Net Margin %(computed)-880.70%62.17%-683.65%
Per Share & EBITDA
EPS (Basic)$-1.65$-1.59$-1.89$3.63$-2.06
Wtd Avg Shares0.04B0.03B0.03B0.03B0.03B
EBITDA($0.06B)($0.05B)($0.06B)$0.12B($0.06B)
EBITDA Margin %(computed)-845.62%62.78%-650.18%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · CHF · B

深入了解Molecular Partners AG

关于Molecular Partners AG(MOLN)损益表

Molecular Partners AG(MOLN)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,MOLN实现营收$0.00B,毛利润$0.00B(毛利率—),净利润($0.06B)(净利率—)。

常见问题

MOLN · 4 问

Molecular Partners AG(MOLN)2025财年营收为$0.00B,同比down100.0%。

MOLN revenueMOLN salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09